Ozone Therapy for Covid 19 patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/07/026671
- Lead Sponsor
- Bisleri charitable trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients confirmed to be COVID-19 positive by quantitative real time polymerase chain reaction (QRT-PCR) assay
2. Patients that meet any one of the criteria of moderate stage
3. Patients who give written informed consent.
4. Age 18 â?? 65 years
1. Mild or severe stage
2. G6PD deficiency
3. Hyperthyroidism
4. Bleeding disorders (any coagulopathies)
5. Chronic uncontrolled illnesses such as uncontrolled diabetes, uncontrolled hypertension chronic renal failure, chronic liver disease, chronic neurodegenerative disorders, chronic heart conditions (chronic heart failure, chronic angina, previous
myocardial infarction), malignancies, etc.,
6. Pregnant and lactating women
7. Patients on immunosuppressant drugs
8. Patients with a history of organ transplantation
9. Patients who are participating in other clinical trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a. Time to recovery on 8 point ordinal scale (Time to reach point 6-8) <br/ ><br>b. Time to Resolution of symptoms (Fever, cough, respiratory rate, shortness of <br/ ><br>breath) <br/ ><br>c. PAO2/FiO2 <br/ ><br>d. Chest X-ray â?? Day 1, 7 & 14 <br/ ><br>e. Inflammatory Biomarkers: <br/ ><br>C- reactive Protein,IL-6,Ferritin,LDH, D-Dimer <br/ ><br>e. Percentage of patients declining to serious stage at the end of 14 days <br/ ><br>f. Percentage of patients improving to mild stage at the end of 14 daysTimepoint: Day 1 <br/ ><br>Day 3 <br/ ><br>Day 6 <br/ ><br>Day 10 <br/ ><br>Day 14
- Secondary Outcome Measures
Name Time Method a. Oxygen saturation index: SPO2 / FiO2 <br/ ><br>b. Total blood count: WBC, Hemoglobin, RBC <br/ ><br>c. Liver Function Test: SGOT, SGPT, Total and Direct Bilirubin <br/ ><br>d. Renal Function Test: BUN Creatinine <br/ ><br>e. Serum electrolytes <br/ ><br>f. Cardiac Function: Troponin and ECG <br/ ><br>g. Percentage Mortality <br/ ><br>h. Cumulative incidence of serious adverse events <br/ ><br>i. Duration of hospitalization <br/ ><br>j. Duration of new oxygen use <br/ ><br>k. SOFA scoreTimepoint: Day 1 <br/ ><br>Day 3 <br/ ><br>Day 6 <br/ ><br>Day 10 <br/ ><br>Day 14